20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs

If the FDA approves a drug for a neglected tropical disease, the company gets a voucher that accelerates review of another drug. This remains controversial.
By Published On: Aprile 19, 2026Categories: DesignCommenti disabilitati su 20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs

Share This Story, Choose Your Platform!

About the author : admin